Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2218 USD | -5.99% | +2.73% | +206.78% |
05-09 | Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-18 | Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 1
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Brachytherapy Devices
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -46.57% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -46.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Korenko
CEO | Chief Executive Officer | 77 | 30/11/16 |
Carlton Cadwell
CHM | Chairman | 79 | 31/12/05 |
Michael Pollack
DFI | Director of Finance/CFO | 57 | 30/11/18 |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | 67 | - | |
Fu-Min Su
PRN | Corporate Officer/Principal | - | 31/12/06 |
Alan R. Merkle
LAW | General Counsel | - | - |
Donald A. Ludwig
PRN | Corporate Officer/Principal | - | - |
General Counsel | 76 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carlton Cadwell
CHM | Chairman | 79 | 31/12/05 |
Michael Korenko
CEO | Chief Executive Officer | 77 | 30/11/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 200,363 | 0 | 0 | 95.15 % |
Stock B | 0 | 2,071,007 | 0 | 0 | |
Stock C | 1 | 401,033,867 | 381,601,298 ( 95.15 %) | 11,000,000 ( 2.743 %) | |
Stock D | 0 | 385,302 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+206.78% | 91.11M | |
-16.58% | 12.9B | |
-11.50% | 2.49B | |
-48.07% | 2.37B | |
-28.34% | 1.19B | |
-.--% | 1.12B | |
+79.49% | 478M | |
+2.35% | 377M | |
+28.10% | 279M | |
-13.73% | 199M |
- Stock Market
- Equities
- RDGL Stock
- Company Vivos Inc.